Immunic, Inc. (IMUX)
7.10
+0.44
(+6.61%)
USD |
NASDAQ |
Oct 15, 16:00
7.10
0.00 (0.00%)
After-Hours: 20:00
Immunic Cash from Operations (TTM) : -87.72M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -87.72M |
| March 31, 2026 | -81.33M |
| December 31, 2025 | -85.81M |
| September 30, 2025 | -89.49M |
| June 30, 2025 | -90.15M |
| March 31, 2025 | -82.57M |
| December 31, 2024 | -84.77M |
| September 30, 2024 | -75.83M |
| June 30, 2024 | -72.34M |
| March 31, 2024 | -75.28M |
| December 31, 2023 | -70.83M |
| September 30, 2023 | -71.90M |
| June 30, 2023 | -68.19M |
| March 31, 2023 | -63.98M |
| December 31, 2022 | -65.14M |
| September 30, 2022 | -73.72M |
| June 30, 2022 | -77.72M |
| March 31, 2022 | -90.97M |
| December 31, 2021 | -83.23M |
| September 30, 2021 | -73.52M |
| June 30, 2021 | -67.82M |
| March 31, 2021 | -48.04M |
| December 31, 2020 | -46.12M |
| September 30, 2020 | -38.70M |
| June 30, 2020 | -32.77M |
| Date | Value |
|---|---|
| March 31, 2020 | -34.53M |
| December 31, 2019 | -28.82M |
| September 30, 2019 | -25.72M |
| June 30, 2019 | -21.83M |
| March 31, 2019 | -1.981M |
| December 31, 2018 | -9.738M |
| September 30, 2018 | -16.21M |
| June 30, 2018 | -23.54M |
| March 31, 2018 | -42.56M |
| December 31, 2017 | -40.40M |
| September 30, 2017 | -39.58M |
| June 30, 2017 | -38.05M |
| March 31, 2017 | -36.73M |
| December 31, 2016 | -35.77M |
| September 30, 2016 | -35.96M |
| June 30, 2016 | -40.11M |
| March 31, 2016 | -46.40M |
| December 31, 2015 | -49.95M |
| September 30, 2015 | -51.05M |
| June 30, 2015 | -50.21M |
| March 31, 2015 | -44.97M |
| December 31, 2014 | -40.82M |
| September 30, 2014 | -40.57M |
| June 30, 2014 | -37.48M |
| March 31, 2014 | -33.46M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Sionna Therapeutics, Inc. | -75.92M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |
| Savara, Inc. | -110.38M |